Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Clinical Trials in Tianjin

Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma